Thyrocare Technologies Limited announced at the board meeting held on January 28, 2022, the directors approved appointment of Mr. Sachin Salvi, presently working as Senior Vice-President-Finance, as Chief Financial Officer of the Company effective from 28th January 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
653 INR | -0.28% | +5.97% | +1.47% |
05-14 | Transcript : Thyrocare Technologies Limited, Q4 2024 Earnings Call, May 14, 2024 | |
05-14 | Thyrocare Technologies Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.47% | 414M | |
-19.54% | 8.05B | |
+68.16% | 4.32B | |
+6.69% | 2.74B | |
-2.98% | 2.6B | |
-50.95% | 1.97B | |
-18.54% | 1.68B | |
-21.29% | 1.45B | |
+16.69% | 1.2B | |
-44.86% | 1.12B |
- Stock Market
- Equities
- THYROCARE Stock
- News Thyrocare Technologies Limited
- Thyrocare Technologies Limited Appoints Sachin Salvi as Chief Financial Officer